Table 2.
Five most common NPDS exposures associated with intubation by age group and as a percentage of total NPDS exposures 2000–2013
| Exposure | Number of exposures to substance reported to NPDS associated with intubation | Total number of exposures to substance reported to NPDS | Percentagea of total NPDS exposures to substance that were associated with intubation (95 % C.I.) |
|---|---|---|---|
| Age 0–5 years | |||
| Single exposures | |||
| Clonidine | 856 | 21,675 | 3.9 % (3.6 to 4.2 %) |
| Carbamazepine | 326 | 11,035 | 2.9 % (2.6 to 3.3 %) |
| Unknown | 285 | 61,492 | 0.5 % (0.4 to 0.5 %) |
| Lamp Oils | 238 | 25,522 | 0.9 % (0.8 to 1.0 %) |
| Atypical Antipsychotics | 142 | 32,083 | 0.4 % (0.4 to 0.5 %) |
| Multiple exposures | |||
| Clonidine | 1052 | 6246 | 16.8 % (15.9 to 17.8 %) |
| Carbamazepine | 367 | 1994 | 18.5 % (16.7 to 20.2 %) |
| Unknown | 336 | 5324 | 6.3 % (5.7 to 7.0 %) |
| Atypical Antipsychotics | 294 | 11,304 | 2.6 % (2.3 to 2.9 %) |
| Lamp Oils | 240 | 1134 | 21.1 % (18.8 to 23.7 %) |
| Age 6–12 years | |||
| Single exposures | |||
| Unknown | 122 | 9817 | 1.2 % (1.0 to 1.5 %) |
| Clonidine | 77 | 13,130 | 0.6 % (0.5 to 0.7 %) |
| Carbon Monoxide | 64 | 17,674 | 0.4 % (0.3 to 0.5 %) |
| Amitriptyline | 60 | 1839 | 3.3 % (2.5 to 4.2 %) |
| Atypical Antipsychotics | 56 | 15,209 | 0.4 % (0.3 to 0.5 %) |
| Multiple exposures | |||
| Atypical Antipsychotics | 550 | 11,187 | 4.9 % (4.5 to 5.3 %) |
| Unknown | 146 | 1187 | 12.3 % (10.5 to 14.3 %) |
| Clonidine | 106 | 5410 | 2.0 % (1.6 to 2.4 %) |
| Benzodiazepines | 102 | 2810 | 3.6 % (3.0 to 4.4 %) |
| Carbon Monoxide | 93 | 773 | 12.0 % (9.8 to 14.5 %) |
| Age 13–19 years | |||
| Single exposures | |||
| Unknown | 759 | 26,374 | 2.9 % (2.7 to 3.1 %) |
| Atypical Antipsychotics | 623 | 37,615 | 1.7 % (1.5 to 1.8 %) |
| Ethanol | 612 | 26,917 | 2.3 % (2.1 to 2.5 %) |
| Amitriptyline | 590 | 4674 | 12.6 % (11.7 to 13.6 %) |
| Diphenhydramine | 315 | 29,871 | 1.1 % (0.9 to 1.2 %) |
| Multiple exposures | |||
| Atypical Antipsychotics | 3082 | 42,425 | 7.3 % (7.0 to 7.5 %) |
| Benzodiazepines | 2747 | 45,410 | 6.0 % (5.8 to 6.3 %) |
| Ethanol | 2347 | 48,605 | 4.8 % (4.6 to 5.0 %) |
| SSRI | 2126 | 56,855 | 3.7 % (3.6 to 3.9 %) |
| Anticonvulsants | 1385 | 19,716 | 7.0 % (6.7 to 7.4 %) |
| Age over 19 years | |||
| Single exposures | |||
| Unknown | 6391 | 73,085 | 8.7 % (8.5 to 9.0 %) |
| Atypical Antipsychotics | 5980 | 116,012 | 5.2 % (5.0 to 5.3 %) |
| Amitriptyline | 4815 | 26,020 | 18.5 % (18.0 to 19.0 %) |
| Benzodiazepines | 4605 | 223,103 | 2.1 % (2.0 to 2.1 %) |
| Acetaminophen Combo | 1984 | 78,624 | 2.5 % (2.4 to 2.6 %) |
| Multiple exposures | |||
| Benzodiazepines | 58,633 | 476,778 | 12.3 % (12.2 to 12.4 %) |
| Atypical Antipsychotics | 35,274 | 212,317 | 16.6 % (16.5 to 16.8 %) |
| Ethanol | 34,611 | 446,504 | 7.7 % (7.8 to 7.8 %) |
| SSRI | 19,661 | 219,181 | 9.0 % (8.9 to 9.1 %) |
| Other Antidepressants | 15,708 | 122,849 | 12.8 % (12.6 to 13.0 %) |
aPercentage values were rounded to the nearest tenth of a percent